NCT03054623 (DRIL) is a clinical trial of DRIL procedure in Steal Syndrome, sponsored by University of South Florida.

Who is sponsoring NCT03054623?

NCT03054623 is sponsored by University of South Florida.

What drugs are being tested in NCT03054623?

Interventions in NCT03054623: DRIL procedure.

What condition does NCT03054623 study?

NCT03054623 studies Steal Syndrome, Chronic Kidney Diseases, Arterio-Venous Fistula.

Is NCT03054623 still recruiting?

NCT03054623 is currently terminated. Last updated 24 January 2025.

Last reviewed 2025-01-24 · How we verify

NCT03054623: DRIL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hemodynamic Assessment of Distal Revascularization Interval Ligation

Terminated Last updated 24 January 2025

What this trial tests

trial testing DRIL procedure in Steal Syndrome in 4 participants. Terminated before completion.

Timeline

20 September 2016

Primary endpoint
11 August 2018

11 August 2018

Quick facts

Lead sponsor	University of South Florida
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	4
Start date	20 September 2016
Primary completion	11 August 2018
Estimated completion	11 August 2018
Sites	2 locations across United States

Drugs / interventions tested

DRIL procedure

Conditions studied

Steal Syndrome — all drugs for Steal Syndrome →
Chronic Kidney Diseases — all drugs for Chronic Kidney Diseases →
Arterio-Venous Fistula — all drugs for Arterio-Venous Fistula →

Sponsor

University of South Florida

Who can join

18 and older, any sex, with Steal Syndrome or Chronic Kidney Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our study seeks to define the effect of each component of the distal revascularization interval ligation (DRIL) procedure on the in vivo distal blood pressure of patients with ischemic steal, and to determine whether the interval ligation component of the DRIL procedure is necessary or not.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of South Florida trials

Trials by the same sponsor.

NCT07529366 — Pharmacist-Led Continuous Glucose Monitoring for Prediabetes · recruiting
NCT07342569 — The WeACT Program for Family Caregivers of People Living With Dementia · NA · not yet recruiting
NCT07502378 — Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic · Phase 4 · recruiting
NCT07241260 — Hydrate Heroes for Improving Brain Function & Mood · NA · not yet recruiting
NCT06377215 — Understanding Aided Speech Perception in Noise · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03054623 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of South Florida
Last refreshed: 24 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03054623.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing